The therapeutic potential of targeting the metabolic enzyme MAT2A in multiple myeloma

Biochemistry, Genetics and Molecular Biology

• Enzyme 100%
• Methylation 100%
• DNA Methylation 75%
• S-Adenosyl Methionine 75%
• Histone Methylation 75%
• Genetics 50%
• Small Molecule 25%
• Gene Targeting 25%
• Methionine 25%
• Anabolism 25%
• Cell Proliferation 25%
• Programmed Cell Death 25%
• Immunoglobulin Producing Cell 25%
• DNA Repair 25%
• DNA Damage 25%
• Cell Survival 25%
• Tumor Volume 25%
• Multidrug Resistance 25%
• Gene Expression Profiling 25%
• Cell Viability 25%
• Drug Resistance 25%
• Protein Biosynthesis 25%
• Cell Cycle Progression 25%
• Mammalian Target of Rapamycin 25%
• RNA Sequencing 25%
• DNA Damage Response 25%

Neuroscience

• Methylation 100%
• Enzyme 100%
• DNA Methylation 75%
• Histone Methylation 75%
• S Adenosylmethionine 75%
• Drug Resistance 50%
• Genetics 50%
• Anabolism 25%
• Programmed Cell Death 25%
• DNA Damage 25%
• Cell Line 25%
• Cell Proliferation 25%
• Immunoglobulin Producing Cell 25%
• Cell Survival 25%
• Gene Delivery 25%
• DNA Repair 25%
• Protein Biosynthesis 25%
• Transcriptome 25%
• Cell Viability 25%
• Bortezomib 25%
• DNA Damage Response 25%
• Cell Cycle Progression 25%
• RNA-Seq 25%
• Methionine Adenosyltransferase 25%
• Biosynthesis 25%

Immunology and Microbiology

• Multiple Myeloma 100%
• Myeloma Cell 36%
• Methylation 21%
• DNA Methylation 15%
• Histone Methylation 15%
• Gene Targeting 5%
• Cell Proliferation 5%
• DNA Damage 5%
• Programmed Cell Death 5%
• Cell Survival 5%
• Immunoglobulin Producing Cell 5%
• Multiple Myeloma Cell Line 5%
• Tumor Volume 5%
• Drug Resistance 5%
• Gene Expression Assay 5%
• DNA Repair 5%
• Methionine 5%
• Cell Viability 5%
• Cell Cycle Progression 5%
• Protein Synthesis 5%
• Multidrug Resistance 5%
• DNA Damage Response 5%
• RNA Sequencing 5%
• Biosynthesis 5%